Last reviewed · How we verify

NCT04364542

Suprascapular Nerve Block Efficacy for Shoulder Surgery

Status unknown NA Last updated 28 April 2020
What this trial tests

NA trial testing Suprascapular nerve block in Shoulder Pain in 98 participants. Status unknown.

Timeline
10 May 2020
Primary endpoint
30 June 2021
30 August 2021

Quick facts

Lead sponsorIvan Simionato
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment98
Start date10 May 2020
Primary completion30 June 2021
Estimated completion30 August 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Ivan Simionato

Who can join

Adults 18 to 80, any sex, with Shoulder Pain or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the analgesia induced by suprascapular nerve block in comparison to interscalene nerve block in arthroscopic rotator cuff repairs. The experimental and the control group will receive the suprascapular nerve block and interscalene nerve block, respectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Suprascapular nerve block

Trials testing the same drug.

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04364542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing